These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23306212)

  • 1. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.
    Lai YH; Yu SL; Chen HY; Wang CC; Chen HW; Chen JJ
    Carcinogenesis; 2013 May; 34(5):1069-80. PubMed ID: 23306212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
    Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
    Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.
    Wang CC; Lin SY; Lai YH; Liu YJ; Hsu YL; Chen JJ
    PLoS One; 2012; 7(4):e33772. PubMed ID: 22529897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
    Chen HW; Lee JY; Huang JY; Wang CC; Chen WJ; Su SF; Huang CW; Ho CC; Chen JJ; Tsai MF; Yu SL; Yang PC
    Cancer Res; 2008 Sep; 68(18):7428-38. PubMed ID: 18794131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
    Wang CC; Tsai MF; Dai TH; Hong TM; Chan WK; Chen JJ; Yang PC
    Cancer Res; 2007 May; 67(10):4816-26. PubMed ID: 17510411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
    Chang TP; Yu SL; Lin SY; Hsiao YJ; Chang GC; Yang PC; Chen JJ
    Cancer Res; 2010 Feb; 70(4):1656-67. PubMed ID: 20145123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.
    Wang CC; Tsai MF; Hong TM; Chang GC; Chen CY; Yang WM; Chen JJ; Yang PC
    Oncogene; 2005 Jun; 24(25):4081-93. PubMed ID: 15782117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates.
    Yan H; Zhu Y; Liu B; Wu H; Li Y; Wu X; Zhou Q; Xu K
    Br J Nutr; 2011 Dec; 106(12):1779-91. PubMed ID: 21733335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
    Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
    Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
    Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles.
    Kumar VB; Yuan TC; Liou JW; Yang CJ; Sung PJ; Weng CF
    Mutat Res; 2011 Feb; 707(1-2):42-52. PubMed ID: 21185843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
    Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
    Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer.
    Lim JC; Chan TK; Ng DS; Sagineedu SR; Stanslas J; Wong WS
    Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):300-10. PubMed ID: 22017767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.